FAKTOR-OPTIONSSCHEIN - INCYTE CO. | Market Closed - Boerse Frankfurt Warrants 01:17:11 29/06/2024 am IST | ||
| 0.16 EUR | +14.29% |
|
| Current month | -37.50% | ||
| 1 month | -42.31% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
INCYTE CORPORATION
Latest news about INCYTE CORPORATION
More news
| Date | Price | Change |
|---|---|---|
| 28/24/28 | 0.15 | +7.14% |
| 27/24/27 | 0.14 | +7.69% |
| 26/24/26 | 0.13 | +18.18% |
| 25/24/25 | 0.11 | 0.00% |
| 24/24/24 | 0.11 | 0.00% |
Real-time Boerse Frankfurt Warrants
Last update June 29, 2024 at 01:17 am IST
More quotesStatic data
| Product type | Exotic Products |
|---|---|
| Buy / Sell | CALL |
| Underlying | INCYTE CORPORATION |
| Issuer | 
Société Générale
|
| WKN | SD416Q |
| ISIN | DE000SD416Q0 |
| Date issued | 29/03/2021 |
| Strike | 79.94 $ |
| Maturity | Unlimited |
| Parity | 1 : 1 |
| Emission price | 8.46 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 19.46 € |
|---|---|
| Lowest since issue | 0.1 € |
| Spread | 0.01 € |
| Spread % | 6.25% |
Company Profile
Incyte Corporation specializes in the research & development of therapeutic products mainly intended for the treatment of cancers and inflammatory disorders. Net sales break down by revenue source as follows:
- product sales (85.6%);
- royalties (14.2%);
- income from research and cooperation agreements (0.2%).
Sector
-
Consensus: Incyte Corporation
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
25
Last Close Price
60.62
USD
Average target price
72.8
USD
Spread / Average Target
+20.09%
- Stock Market
- Certificates
- Certificat
